Join us this week for the MDTP student seminar, featuring Joie Ling from Hryckowian Lab!
#MDTP #UWMadison
23.02.2026 18:13
π 4
π 2
π¬ 0
π 0
Postdoc, Postgrad, and Research Intern Vacancies
Browse Postoc and Research Intern vacancies at UWβMadison.
Postdoc position available in my lab! Project will focus on how the microbiome-derived metabolite butyrate shapes C. difficile fitness and pathogenesis & will build on our previous/ongoing work in this space. Apply here:
hr.wisc.edu/postdoc-and-...
06.02.2026 17:26
π 13
π 13
π¬ 0
π 0
Next Monday, December 8th, Anna Gregory from the Hryckowian Lab will be giving her dissertation defense seminar!
02.12.2025 20:02
π 5
π 2
π¬ 0
π 0
Thank you Erin!
10.11.2025 13:45
π 1
π 0
π¬ 0
π 0
Thank you Vaughn. Tell the 'Burgh I said Hi π
10.11.2025 00:00
π 1
π 0
π¬ 0
π 0
Thank you Heidi!
10.11.2025 00:00
π 0
π 0
π¬ 0
π 0
Thank you Mark!
10.11.2025 00:00
π 1
π 0
π¬ 0
π 0
Thank you! Iβm honored to receive the Vilas Early-Career Investigator Award and I deeply appreciate the recognition from my colleagues in MMI and from Dean Ahuja. Looking forward to the awesome science this will catalyze π
09.11.2025 23:59
π 2
π 0
π¬ 1
π 0
The emerging view on the roles of butyrate in Clostridioides difficile pathogenesis | Infection and Immunity
The Centers for Disease Control and Prevention classifies Clostridioides difficile as an urgent threat to the nationβs health, as it causes 450,000 infections, 15,000 deaths, and 1 billion dollars in excess healthcare costs per year in the United States (1, 2). Most C. difficile infections (CDIs) occur in healthcare settings, where CDI is the most common cause of infectious diarrhea (3). Known and suspected risk factors for CDI include antibiotics, proton pump inhibitors, impaired immune function, advanced age, and diet, all of which are associated with dysbiotic gastrointestinal (GI) microbiomes (4β6). Though most CDIs are associated with antibiotic treatment, 22% of individuals with community-acquired CDI have no recent history of antibiotic use. Factors affecting persistent and recurrent CDIs remain poorly defined (7, 8). Despite the morbidity and mortality caused by C. difficile, up to 15% of healthy adults are asymptomatic carriers of toxigenic C. difficile (9), highlighting the gaps in our understanding of C. difficile.
Thrilled to share @alex-dobrila.bsky.socialβs new review in Infection & Immunity on how butyrate shapes C. difficile pathogenesis. A must-read for those interested in microbiomeβpathogen interactions. π journals.asm.org/doi/10.1128/...
24.09.2025 17:08
π 16
π 5
π¬ 3
π 0
Check out Anna Gregory's great work, recently published in Journal of Bacteriology. Thanks for the shout out, @smitslab.bsky.social π
07.02.2025 21:52
π 3
π 0
π¬ 0
π 0